Home
Storia in 1 fonti
Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate
Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate
Raccontata da
morningstar.com
Timeline cronologica
- ·
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate
- ·
Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate
Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate